Gara Jalqabaatti › Obesity › Louisiana

Qorannoo klinikaalii Obesity Louisiana keessatti

Qorannoo 33 Obesity f Louisiana keessatti hirmaatuu jiru.

Magaalota Louisiana keessatti

Takkalaa qorannoo (Ingiliffa)

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Velocity Clinical Research - Baton Rouge, Baton Rouge
Tandem Clinical Research - Marrero, Marrero

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ima Clinical Research- Monroe, Monroe

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Cardiovascular Associates Research, LLC, Covington
Tandem Clinical Research - Marrero, Marrero

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Pennington Biomed Res Ctr, Baton Rouge

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

BRCR Global Louisiana, Gretna

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07837973

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Southern Clin Research, Zachary

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Care Access - New Iberia, New Iberia
Louisiana Research Center, Shreveport

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Velocity Clinical Research, Lafayette

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Care Access - New Iberia, New Iberia
Louisiana Research Center, Shreveport

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

IMA Clinical Research Monroe - Armand, Monroe

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
IMA Clinical Research Monroe - Armand, Monroe

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Care Access - Shreveport 2, Shreveport

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Care Access - Lake Charles (Bayou Pines), Lake Charles

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Monroe

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

Pennington Generation Cohort

Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin hundi · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06849206

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Baton Rouge
AURORA-2 Clinical Site, Metairie

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Our Lady of the Lake Medical Center, Baton Rouge
Louisiana Heart Center - Hammond, Covington
Heart Clinic of Hammond, Hammond
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Baton Rouge

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Elevate Clinical Research, Lake Charles
Nola Care Clinical Research Center, Metairie
DelRicht Clinical Research, LLC, New Orleans

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ascension DePaul Health, New Orleans

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351045

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Shreveport

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera Clinical Site, Shreveport

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Grace Research, LLC, Bossier City
Horizon Research Group of Opelousas, LLC, Eunice
Cardiovascular Institute of the South, Houma
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07567001

Collaborative Multi-level Obesity Intervention Engaging Communities Trial

InclusivCare - Avondale Clinic, Avondale
CommuniHealth Services - Bastrop Clinic, Bastrop
CareSouth Medical and Dental - Baton Rouge Clinic, Baton Rouge
fi 15 dabalataa

Namoota walitti qabaa jira

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06835686

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Baton Rouge

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Tandem Clinical Research, Marrero

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07477704

Low Oxygen Exposure and Weight Status

Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT05289310

Body Composition Outcomes in MS Patients

Pennington Biomedical Resarch Center, Baton Rouge
Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT07530718

Experimental Approach to Test Predictions of Body Weight Regulation Models

Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 hanga 40 · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT06309576

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 hanga 42 · Saalaa hunda · Haaromfame 08-Elb-2026 · NCT04583514

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

Pennington Biomedical Research Center, Baton Rouge

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 hanga 45 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06602141

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

Tulane University School of Public Health and Tropical Medicine, New Orleans

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 fi ol · Dubartoota · Haaromfame 25-Ado-2025 · NCT06116149

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.